Amphetamine Extended-release Oral Suspension
NDC Package 66993-360-87

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Amphetamine Extended-release Oral Suspension is a . Marketed by Prasco Laboratories, this product is identified by NDC 66993-360 and is authorized under FDA application NDA204325.

Identification & Billing

NDC Package Code
66993-360-87
Package Description
450 mL in 1 BOTTLE, GLASS
Product Code
66993-360
11-Digit Billing Format
66993036087
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
450 ML

Clinical Specifications

Proprietary Name
Amphetamine Extended-release Oral Suspension
Dosage Form
-

Regulatory & Marketing

Labeler Name
Prasco Laboratories
FDA Application #
NDA204325
Marketing Category
NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
Start Marketing Date
09-30-2020
End Marketing Date
09-30-2021
Listing Expiration
09-30-2021
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66993-360-87 identifies a specific commercial package of 450 ml in 1 bottle, glass of Amphetamine Extended-release Oral Suspension, labeled by Prasco Laboratories. This product is billed per "ML" milliliter and contains an estimated amount of 450 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Prasco Laboratories on September 30, 2020. The current certification is valid through September 30, 2021.

How is this Prasco Laboratories product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66993036087. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 450 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
66993-360-87
11-Digit CMS (5-4-2)
66993-0360-87

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.